Skip to content

Eefficacy and safety of azithromycin-based quadruple therapy in patients with helicobacter pylori infection

A randomized controlled trial: efficacy and safety of azithromycin-based quadruple therapy in patients with helicobacter pylori infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011470
Enrollment
Unknown
Registered
2017-05-23
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

helicobacter pylori infection

Interventions

experimental group:proton pump inhibitor, bismuth, azithromycin and cefuroxime
control group:proton pump inhibitor, bismuth, amoxicillin and clarithromycin

Sponsors

Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosis of helicobacter pylori infection; (2) Have no history of allergy to azithromycin and cefuroxime, bismuth agent; (3) Aged 18 to 65 years old, male or female, regardless of gender, nationality.

Exclusion criteria

Exclusion criteria: (1) Pregnant or breast-feeding women; (2) Have taken antibiotics or H2RA or PPI within 2 weeks before treatment; (3) Serious heart, kidney, lung, and liver disease; (4) Drug or alcohol abuse; (5) Can not insist using drugs and participated in other clinical research; (6) Allergic constitution, known or suspected allergy to drugs using in this study; (7) Non-compliant patient; (8) The clinical trial research personnel.

Design outcomes

Primary

MeasureTime frame
the eradication rate;

Secondary

MeasureTime frame
epigastric distention;belching;epigastric pain;diarrhea;loss of appetite;nausea;vomiting;acid regurgitation;heartburn;rash;Oral malodor;bitter taste;

Countries

China

Contacts

Public ContactZHUANG Zehao

Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University

zhuang203@yeah.net+86 13178032412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026